UK Research and Innovation (UKRI) is partnering with leading funders in Southeast Asia to support research focused on infectious diseases with epidemic or antimicrobial resistance (AMR) potential.
This opportunity aims to:
- fund collaborative projects involving the UK and one or more partner countries to address the challenges of AMR and pathogens with epidemic potential of relevance to Southeast Asia
- enhance existing and develop new sustainable partnerships between the UK and Southeast Asia research partners
- strengthen research capacity in the Southeast Asia region through supporting long-term research relationships
UKRI and the Southeast Asia funders participating in this funding opportunity will support collaborative research projects between UK researchers and partners based in Indonesia, Malaysia, Thailand, Philippines, Vietnam, and Singapore. In addition, we welcome collaborations involving Southeast Asia Least Developed Countries (Myanmar, Laos and Cambodia).
Eligibility: To be eligible to apply for this opportunity you must be:
- a research team made up of at least one researcher based at an eligible UK institution and at least one researcher based at an eligible research institution in a Southeast Asia DAC-list country
- include additional researchers based in eligible UK institutions only if there is at least one eligible research institution in a Southeast Asia DAC-list country involved in the project
- include additional researchers based in Southeast Asia institutions only if there is at least one eligible research institution in a Southeast Asia DAC-list country involved in the project
Level of funding: The full economic cost (FEC) of your project requested from UKRI can be up to £1,000,000. UKRI will fund 80% of the FEC for costs requested for UK based researchers and 100% of the FEC for costs requested for researchers based outside of the UK.
Key dates
- 30 May 2024: applications close at 16:00 BST